图片来源：视觉中国 蓝鲸新闻12月17日讯（记者 代紫庭）国资接力，老牌"黑芝麻"要"上岸"了吗？ 近日，南方黑芝麻集团股份有限公司（000716.SZ，以下简称"黑芝麻"）发布关于控股股东协议转让股权暨控制权拟发生变更的进展公告。公告指 出，其控制权变更交易已通过国家市场监督管理总局反垄断审查。 这也意味着，本次交易若顺利通过国资监管与交易所的后续合规审批，便可完成控制权变更的最后一环，使黑芝麻正式实现国资控股。 中国食品产业分析师朱丹蓬对蓝鲸新闻记者指出，黑芝麻长期处于"主业不强、副业过多、战线过长"的困局。在他看来，国资背景的广旅大健康 入主后，或许能够帮助企业整合协调行业资源，盘活存量、拓展增量。 国资9.42亿"接盘"，老品牌寻求上岸 2025年8月8日，公司控股股东广西黑五类食品集团有限责任公司（下称"黑五类集团"）与广西旅发大健康产业集团有限公司（下称"广旅大健 康"）签署了《股份转让协议》。 根据协议，黑五类集团拟通过协议转让方式，将其持有的黑芝麻约1.51亿股（占公司总股本的20%）无限售流通股，以每股6.25元的价格转让给广 旅大健康，转让总价款为9.42亿元。 交易完成后，广旅大健康将持 ...

交易行情显示，截至12月10日午间收盘，黑芝麻当前股价为6.24元/股，涨幅为0.32%，公司总市值约 46.98亿元。 编辑 杨娟娟 校对 杨利 新京报贝壳财经讯（记者阎侠）承载着一代人童年记忆的黑芝麻，或将易主国资文旅企业。12月10日， 黑芝麻发布关于控股股东协议转让股权暨控制权拟发生变更的进展公告。 公告显示，黑芝麻控股股东广西黑五类食品集团有限责任公司（简称"黑五类集团"）与广西旅发大健康 产业集团有限公司（简称"广旅大健康"）已经签署了《股份转让协议》，黑五类集团拟通过协议转让方 式将其持有公司150697910股（占公司总股本20%）的无限售流通股股份转让给广旅大健康；本次股份 转让项下标的股份转让价格为6.25元/股，对应转让价款总额为约9.42亿元（含税）。 本次交易实施完成后，黑芝麻的控股股东将由黑五类集团变更为广旅大健康，实际控制人将由李汉朝、 李汉荣、李玉琦、李玉坚、李玉宇、甘政、李淑娴变更为广西壮族自治区人民政府国有资产监督管理委 员会。 最新进展显示，广旅大健康申报的经营者集中反垄断审查申请已于2025年11月12日获国家市场监督管理 总局受理，并履行了经营者集中反垄断业务公示；截 ...

截至目前，长江产业集团直接持有长江证券股份比例升至17.41%，长江产业集团及其一致行动人合计 持股比例为28.22%，是长江证券第一大股东。 在股权转让期间，长江证券的管理层面也发生了变化。2024年7月，刘正斌就已出任长江证券党委书 记。今年3月初，前任董事长金才玖因工作调整辞职后，刘正斌开始代为履行职务，一个月后正式当 选。 12月9日，长江证券发布多份公告，宣布完成董事会及管理层换届选举。公告显示，刘正斌连任公司第 十一届董事会董事长，陈佳出任副董事长，总裁一职由刘元瑞继续担任。 新一届董事会由刘正斌、陈佳、刘元瑞、李俊喜、陈华军、黄雪强、陈文彬、赵海涛八名非独立董事， 以及朱启贵、徐信忠、李新天、全怡、代昀昊五名独立董事构成。 与前届董事会相比，此次换届新增李俊喜、陈华军以及赵海涛三位湖北国资背景的董事。连同刘正斌在 内，湖北国资在长江证券的董事席位增至4个。 公开资料显示，刘正斌曾任湖北省发改委，李俊喜、陈华军曾分别任职于湖北银行人力资源部、湖北省 仙桃市政府；赵海涛现任湖北宏泰集团党委委员、副总经理，曾任长江产业投资私募基金党委书记、董 事长。 而这一变动也是湖北国资受让原股东三峡集团持有长江证 ...

Core Viewpoint - The control change of Tailong Pharmaceutical to Jiangxi state-owned assets reflects the transformation anxiety of traditional Chinese medicine enterprises amid industry policy changes and intensified market competition, with the potential for state capital to provide crucial support for overcoming development bottlenecks [1][10]. Group 1: Control Change Details - Jiangxi state-owned Jiangyao Holdings will acquire control of Tailong Pharmaceutical through a combination of "share transfer + directed issuance," investing over 1 billion yuan [1][2]. - The share transfer involves Jiangyao Holdings purchasing 50.1 million shares (8.73% of total shares) at 11.043 yuan per share, totaling 553 million yuan, with the transfer occurring in two phases [2]. - To ensure a smooth transition of control, an agreement was signed for joint action, allowing Jiangyao Holdings to control 14.37% of shares during the transition period [2][3]. Group 2: Financial Performance - In the first three quarters of 2025, Tailong Pharmaceutical reported revenue of 1.187 billion yuan, a year-on-year decline of 11.47%, and a net profit of 25.33 million yuan, down 12.36% [4]. - The company faced significant pressure in 2025, with a net profit of only 1.53 million yuan in the first quarter, a drastic drop of 92.80% year-on-year [5]. - The pharmaceutical formulation segment, which has the highest gross margin, saw a revenue decline of 37.73% in the first three quarters of 2025, directly impacting overall profitability [5][6]. Group 3: Strategic Implications of State Capital Involvement - The entry of Jiangxi state capital is expected to provide multiple benefits, including optimization of the industrial chain layout, market channel expansion, and integration of research and development resources [7][8]. - Jiangyao Holdings aims to leverage its extensive channel resources in the pharmaceutical distribution sector to enhance Tailong Pharmaceutical's market penetration and alleviate pricing pressures [7][8]. - The 454 million yuan raised from the directed issuance will be used to improve cash flow and reduce financial costs, providing sufficient funding for operations and research [8]. Group 4: Industry Context and Future Outlook - The involvement of state capital in traditional Chinese medicine enterprises is becoming a significant trend, as local state-owned enterprises frequently invest in the pharmaceutical industry to help traditional companies overcome challenges and transform [10][11]. - The entry of state capital is reshaping the industry landscape, providing financial support and facilitating the concentration of resources towards stronger enterprises [11]. - However, the success of state capital involvement depends on effective management and integration, as past experiences show that not all state-controlled enterprises have improved performance [11].

智通财经记者 | 袁颖琪 君亭酒店（301073.SZ）近日一则控制权变更公告搅动酒店业与资本市场的双重池水。 湖北省属国企湖北文化旅游集团（下称"湖北文旅"）将以18亿元现金完成对君亭酒店的控股。具体来 看，湖北文旅将先以协议转让方式受让君亭酒店创始人团队29.99%股份，再通过部分要约收购拿下 6.01%股份，最终合计持有36%股份，成为控股股东与实际控制人。这意味着，湖北省国资委将正式接 管这家民营高端酒店上市公司。 目前，君亭酒店市值51亿元左右，对应市盈率（PE）达304倍。此次交易对价遵循市价，对应市盈率接 近300倍，而当前酒店行业龙头企业市盈率普遍处于20-50倍区间。在酒店业仍处调整期、君亭酒店自身 净利润同比大幅下滑的背景下，如此悬殊的估值令不少人直呼："湖北文旅买贵了？" 一份精心设计的控制权移交方案 这份精心设计的控制权移交方案，远非一次简单的股权买卖，而是通过一系列环环相扣的安排，确保了 控制权能够平稳且彻底地转移。 核心环节为协议转让。湖北文旅以每股25.71元的价格，受让创始人吴启元、股东从波和施晨宁合计持 有的5831.59万股股份，占总股本的29.99%，转让总价款约15亿元 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 长江商报消息 ●长江商报记者 沈右荣 或涉历时遗留问题，天风证券（601162.SH）被中国证监会立案调查。 11月28日晚，天风证券发布公告，当日，公司收到中国证监会下发的《立案告知书》，因涉嫌信息披露 违法违规、违法提供融资，中国证监会决定对公司立案。 天风证券被证监会立案调查，可能涉及3年前的大股东占资问题。 12月1日，武汉当代科技产业集团股份有限公司（以下简称"当代集团"）在银行间市场披露，公司于11 月28日收到《立案告知书》，因涉嫌信息披露违法违规、违规融资等，被证监会立案。 当代集团是天风证券的前重要股东。一个是违规提供融资，一个是违规融资。据此判断，天风证券被立 案与当代集团或存在关联。 2022年，天风证券曾在回复上交所《监管函》时表示，公司通过自查发现原股东占用上市公司资金问 题，所占资金已经全部归还。 2023年，湖北国资入主天风证券，天风证券随即努力与当代系切割。国资入主后，天风证券逐步走向规 范，基本面得到改善。2025年前三季度，公司盈利1.53亿元，同比扭亏为盈。 或因历史遗留问题被立案 12月1日，当代集团在中国银行间市场交易 ...

Group 1 - The core viewpoint of the article highlights the reasons behind Delong Huineng's stock surge, including state-owned capital entry, governance optimization, and new energy layout [1] Group 2 - Delong Huineng is undergoing a significant transformation, with Dongyang Nuoxin's indirect 49% stake bringing government resource support and a transaction amount of 1 billion yuan, indicating the new shareholder's recognition of the company's value [1] - The company has revised its articles of association and decision-making rules, eliminating the supervisory board to enhance decision-making efficiency [1] - Delong Huineng has proactively mitigated risks by fully provisioning for a 222 million yuan impairment related to Guojun's advance payments, thereby reducing future financial risks [1] - New regulations have strengthened the management of raised funds, improving transparency in fund usage [1] - The company primarily engages in clean energy supply, focusing on natural gas, while also actively expanding into hydrogen energy and photovoltaic sectors, aligning with current energy transition trends [1] Group 3 - The energy sector has recently attracted capital attention, with some natural gas and new energy-related stocks performing actively, contributing to Delong Huineng's stock limit-up potentially due to sector linkage [1] - Data from Dongfang Caifu indicates a certain inflow of funds into the energy sector on the day of the stock surge [1] Group 4 - On the technical front, if the MACD indicator forms a golden cross or breaks through the upper Bollinger Band, it may attract technical investors' attention, further driving up the stock price [1] - Tonghuashun's capital monitoring shows that large orders presented a net buying state on that day, with main funds flowing in to support the stock price limit-up [1]

Group 1 - The controlling shareholder of Chaozhuo Aerospace (688237) will change to Hubei Provincial State-owned Assets Supervision and Administration Commission, with stock resuming trading on December 1 [2][3] - The current controlling shareholders, Li Guangping, Wang Chunxiao, and Li Yihan, will transfer a total of 18.7584 million shares, representing 20.93% of the company's total equity, to Hubei Jiaotong Investment Capital Co., Ltd. at a price of 41.16 yuan per share, totaling 772 million yuan [2][3] - Chaozhuo Aerospace is recognized as a national-level specialized and innovative "little giant" enterprise, focusing on customized additive manufacturing and onboard equipment maintenance, with a leading advantage in cold spray solid additive manufacturing technology [3] Group 2 - The company has established a customer base that includes major military and civil aviation enterprises such as Aviation Industry Corporation of China, China Southern Airlines, and Air China, while also expanding into the civilian sectors of new energy vehicle components and industrial mother machine parts [3] - The entry of state-owned capital is expected to provide strong support for the company's long-term development, as the current equity structure and business scale are insufficient to meet the strategic needs for rapid industry expansion [3] - Hubei Jiaotong Investment Capital, as a wholly-owned subsidiary of Hubei Transportation Investment Group, will offer professional and financial support for future financing, mergers, and acquisitions, enabling dual empowerment of industry and capital [3]

Core Viewpoint - The control change of Xinyaqiang (603155.SH) has been finalized, with the state-owned Hancheng City Chengxin Equity Investment Fund acquiring a 29.9% stake for 1.96 billion yuan, marking a significant shift in the company's governance structure [1][2]. Group 1: Control Change Details - Xinyaqiang's controlling shareholder, Chu Lin, has signed a share transfer agreement with Chengxin Fund, which will pay the total amount in four installments [1]. - After the transfer, Chengxin Fund will become the largest shareholder, while Chu Lin and her brother will see their combined stake drop to 17.61%, losing control of the company [1][2]. - The actual controller will change to the State-owned Assets Supervision and Administration Commission of Hancheng City, integrating the company into the local state-owned asset regulatory system [1]. Group 2: Governance and Commitments - The transfer agreement includes multiple commitments to ensure operational stability, such as Chengxin Fund not transferring control for seven years and Chu Lin not seeking control for 18 months [2]. - The restructured board will consist of seven directors, with three independent directors, and both parties will have the right to nominate directors [2]. Group 3: Financial Performance - Xinyaqiang has faced declining performance over the past four years, with a continuous drop in net profit [3]. - Revenue figures from 2022 to 2024 show a downward trend, with revenues of 1.134 billion yuan, 675 million yuan, and 721 million yuan, reflecting changes of -28.82%, -40.44%, and 6.71% respectively [3]. - The net profit for the same period was 302 million yuan, 123 million yuan, and 114 million yuan, with year-on-year changes of -5.55%, -59.09%, and -7.36% [3]. - In the first three quarters of 2025, revenue decreased by 19.05% to 451 million yuan, and net profit fell by 20.39% to 79 million yuan, primarily due to declining product margins [3]. Group 4: Market Reaction - The market reacted positively to the news of state-owned capital entering the company, with Xinyaqiang's stock price hitting the daily limit on the announcement date and continuing to rise the following day [4]. - As of November 26, the stock closed at 19.82 yuan per share, indicating strong investor interest [4].

Core Viewpoint - The company XinYaqiang (603155.SH) announced a significant change in its controlling shareholder, with the transfer of approximately 94.42 million shares from its current controlling shareholder, Chu Lin, to Handan City Chengxin Equity Investment Fund Partnership, marking a shift in control to the Handan State-owned Assets Supervision and Administration Commission [1][4]. Group 1: Share Transfer Details - Chu Lin signed a share transfer agreement on November 24, selling shares at a price of 20.76 CNY per share, totaling 1.96 billion CNY [1]. - After the transfer, the new controlling shareholder, Chengxin Fund, will hold 29.9% of the company's shares, while Chu Lin will retain 16.09% of the shares [2][3]. - The share transfer price represents a premium of approximately 15.2% over the closing price of 18.02 CNY on November 25, and a premium of about 26.74% over the closing price of 16.38 CNY on November 24 [2]. Group 2: Impact of Control Change - The company stated that the change in control will not affect its main business structure or daily operations, and it will maintain its independent governance and financial integrity [4]. - The Chengxin Fund, established on March 28, 2023, is managed by Shanghai Jincheng Equity Investment Fund Management Co., Ltd., and is committed to not transferring control for seven years and not transferring shares for 18 months post-transfer [4]. Group 3: Company Performance - XinYaqiang has experienced significant fluctuations in performance since its listing, with a continuous decline in net profit over the past three accounting years [5]. - For the first three quarters of this year, the company's revenue decreased by 19.05% to 451 million CNY, and net profit fell by 20.39% to 79 million CNY [5][6].